| Primary |
| Hypersensitivity |
50.3% |
| Product Used For Unknown Indication |
7.5% |
| Nasal Congestion |
5.6% |
| Sinus Disorder |
5.0% |
| Asthma |
4.3% |
| Multiple Allergies |
4.3% |
| Nasopharyngitis |
2.5% |
| Rhinorrhoea |
2.5% |
| Sinus Congestion |
2.5% |
| Blood Immunoglobulin A |
1.9% |
| Lower Respiratory Tract Infection |
1.9% |
| Sneezing |
1.9% |
| Cough |
1.2% |
| Dizziness |
1.2% |
| Dyspnoea |
1.2% |
| Lacrimation Increased |
1.2% |
| Pain |
1.2% |
| Respiratory Tract Congestion |
1.2% |
| Sinus Headache |
1.2% |
| Sinusitis |
1.2% |
|
| Drug Ineffective |
23.1% |
| Medication Residue Present |
16.2% |
| Insomnia |
14.6% |
| Sleep Disorder |
6.9% |
| Therapeutic Response Decreased |
6.9% |
| Somnolence |
4.6% |
| Nausea |
3.1% |
| Blood Pressure Increased |
2.3% |
| Extra Dose Administered |
2.3% |
| Heart Rate Increased |
2.3% |
| Off Label Use |
2.3% |
| Vomiting |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
| Dry Mouth |
1.5% |
| Feeling Abnormal |
1.5% |
| Palpitations |
1.5% |
| Restlessness |
1.5% |
| Sinus Disorder |
1.5% |
| Throat Irritation |
1.5% |
| Unevaluable Event |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
61.5% |
| Hypertension |
7.6% |
| Hypersensitivity |
6.5% |
| Nasal Congestion |
3.1% |
| Muscle Spasms |
2.3% |
| Sneezing |
2.3% |
| Asthma |
1.8% |
| Lacrimation Increased |
1.8% |
| Sinus Disorder |
1.8% |
| Multiple Allergies |
1.6% |
| Cough |
1.3% |
| Pain |
1.3% |
| Nasal Discomfort |
1.0% |
| Rhinorrhoea |
1.0% |
| Throat Irritation |
1.0% |
| Blood Immunoglobulin A |
0.8% |
| Eye Pruritus |
0.8% |
| Migraine |
0.8% |
| Respiratory Tract Congestion |
0.8% |
| Sinus Congestion |
0.8% |
|
| Vestibular Disorder |
14.0% |
| Drug Ineffective |
10.0% |
| Medication Residue Present |
10.0% |
| Insomnia |
8.0% |
| Throat Irritation |
8.0% |
| Drug Hypersensitivity |
6.0% |
| Extra Dose Administered |
6.0% |
| Inappropriate Schedule Of Drug Administration |
4.0% |
| Loss Of Consciousness |
4.0% |
| Nausea |
4.0% |
| Pneumonia |
4.0% |
| Therapeutic Response Decreased |
4.0% |
| Wrong Technique In Drug Usage Process |
4.0% |
| Agitation |
2.0% |
| Drug Ineffective For Unapproved Indication |
2.0% |
| Haemolytic Anaemia |
2.0% |
| Hepatic Cirrhosis |
2.0% |
| Hypothyroidism |
2.0% |
| Nervousness |
2.0% |
| Off Label Use |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.3% |
| Asthma |
10.6% |
| Hypersensitivity |
10.1% |
| Drug Use For Unknown Indication |
6.1% |
| Pain |
6.0% |
| Multiple Allergies |
4.6% |
| Rheumatoid Arthritis |
4.6% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Depression |
4.0% |
| Osteoporosis |
3.5% |
| Hormone Replacement Therapy |
2.6% |
| Anxiety |
2.1% |
| Dyspnoea |
2.1% |
| Multiple Sclerosis |
2.1% |
| Prophylaxis |
2.0% |
| Rhinitis Allergic |
2.0% |
| Seasonal Allergy |
1.8% |
| Sleep Disorder |
1.8% |
| Acne |
1.7% |
| Contraception |
1.7% |
|
| Pulmonary Embolism |
13.7% |
| Sinusitis |
11.6% |
| Vomiting |
9.5% |
| Pain |
6.3% |
| Upper Respiratory Tract Infection |
6.3% |
| Drug Ineffective |
5.3% |
| Nausea |
4.2% |
| Thrombophlebitis Superficial |
4.2% |
| Tremor |
4.2% |
| Deep Vein Thrombosis |
3.2% |
| Local Swelling |
3.2% |
| Myocardial Infarction |
3.2% |
| Paraesthesia |
3.2% |
| Platelet Count Decreased |
3.2% |
| Staphylococcal Infection |
3.2% |
| Urticaria |
3.2% |
| Vision Blurred |
3.2% |
| Weight Decreased |
3.2% |
| Weight Increased |
3.2% |
| Withdrawal Syndrome |
3.2% |
|
| Interacting |
| Nasal Congestion |
50.0% |
| Postnasal Drip |
50.0% |
|
|
